Skip to content

AptarGroup ATR Free cash flow

Free cash flow at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Amcor logo
AmcorAMCR
Nordson logo
NordsonNDSN
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's free cash flow?
AptarGroup (ATR) reported free cash flow of $53.3M in Q1 2026.
How has AptarGroup's free cash flow changed year-over-year?
AptarGroup's free cash flow increased by 105.9% year-over-year, from $25.88M to $53.3M.
What is the long-term trend for AptarGroup's free cash flow?
Over 4 years (2021 to 2025), AptarGroup's free cash flow has grown at a 52.4% compound annual growth rate (CAGR), from $55.51M to $299.58M.